Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Bengt eWinblad"'
Autor:
Babette eReijs, Charlotte Elisabeth Teunissen, Nikolai eGoncharenko, Fay eBetsou, Kaj eBlennow, Inês eBaldeiras, Frederic eBrosseron, Enrica eCavedo, Tormod eFladby, Lutz eFroelich, Tomasz eGabryelewicz, Hakan eGurvit, Elisabeth eKapaki, Peter eKoson, Luka eKulic, Sylvain eLehmann, Piotr eLewczuk, Alberto eLleó, Walter eMaetzler, Alexandre ede Mendonça, Anne-Marie eMiller, José Luis eMolinuevo, Brit eMollenhauer, Lucilla eParnetti, Uros eRot, Anja eSchneider, Anja Hviid Simonsen, Fabrizio eTagliavini, Magda eTsolaki, Marcel M Verbeek, Marzena eZboch, Frans R Verhey, Bengt eWinblad, Philip eScheltens, Henrik eZetterberg, Pieter Jelle eVisser
Publikováno v:
Frontiers in Neurology, Vol 6 (2015)
AbstractBiobanks are important resources for biomarker discovery and assay development. Biomarkers for Alzheimer's and Parkinson's Disease (BIOMARKAPD) is a European multicenter study, funded by the EU Joint Programme - Neurodegenerative Disease Rese
Externí odkaz:
https://doaj.org/article/c94931ab125f456c8ce268fff21d6830
Autor:
Ulf eAndreasson, Armand ePerret-Liaudet, Linda evan Waalwijk van Doorn, Kaj eBlennow, Davide eChiasserini, Sebastiaan. eEngelborghs, Tormod eFladby, Sermin eGenc, Niels eKruse, Bea eKuiperij, Luka eKulic, Piotr eLewczuk, Brit eMollenhauer, Barbara eMroczko, Lucilla eParnetti, Eugeen eVanmechelen, Marcel eVerbeek, Bengt eWinblad, Henrik eZetterberg, Marleen eKoel - Simmelink, Charlotte Elisabeth Teunissen
Publikováno v:
Frontiers in Neurology, Vol 6 (2015)
Biochemical markers have a central position in the diagnosis and management of patients in clinical medicine, and also in clinical research and drug development, also for brain disorders such as Alzheimer’s disease. The enzyme-linked immunosorbent
Externí odkaz:
https://doaj.org/article/d941d9232ecb495eb426ac077775327b
Autor:
Johan eLundkvist, Magnus eHalldin, Johan eSandin, Gunnar eNordvall, Pontus eForsell, Samuel eSvensson, Liselotte eJansson, Gunilla eJohansson, Bengt eWinblad, Jonas eEkstrand
Publikováno v:
Frontiers in Pharmacology, Vol 5 (2014)
Alzheimer Disease (AD) is the most common form of dementia, affecting approximately 36 million people worldwide. To date there is no preventive or curative treatment available for AD, and in absence of major progress in therapeutic development, AD ma
Externí odkaz:
https://doaj.org/article/116ed33718d742258d6941acb762a921